Why the study?
Does low dose subcutaneous heparin prevent deep vein thrombosis in patients undergoing major gynaecological surgery?
Does low dose subcutaneous heparin prevent deep vein thrombosis in patients undergoing major gynaecological surgery?
Low-dose subcutaneous heparin significantly reduces the incidence of deep vein thrombosis following major gynaecological surgery.
Answers are grounded in this paper and cite their sources.
May warrant low-dose heparin for DVT prophylaxis in major gynaecological surgery; extends evidence from other surgical populations.
Summary The prophylactic effect of low doses of subcutaneous heparin in the prevention of deep vein thrombosis after major gynaecological surgery was investigated in a clinical trial involving 110 patients. Evidence of thrombosis was detected by the 1251‐labelled fibrinogen test in 16 out of 55 patients (29 per cent) in the control group, and in 2 out of 55 patients (3.6 per cent) in the heparin‐treated group. Only longevity had a significant association with the development of deep vein thrombosis.
No takes yet. Share an insight, caveat, or question.
Ballard et al. (1973) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: